EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Chinese Family With Knobloch Syndrome Associated With a Novel PAK2 Variant Leading to Reduced Phosphorylation Levels

Liwei Shen, Xiaofei Ye, Xiaocui Wang, Conglei Song, Bin Yang iD

Molecular Genetics & Genomic Medicine · 2025

DOI: 10.1002/mgg3.70099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, 2025. Verfasst von Liwei Shen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Anhui Provincial Children's Hospital/Children's Hospital of Fudan University (Affiliated Anhui Branch), Hefei, China. Hauptthemen laut MEDLINE: p21-Activated Kinases. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Anhui Medical University Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Biallelic variants of COL18A1 cause Knobloch syndrome (KNO), a rare genetic disorder, characterized by oculopathy and structural defects. Recently, several studies have suggested that novel de novo missense variants in PAK2 may be associated with KNO; however, there are few case reports. This study aimed to investigate a patient with KNO who initially presented with seizures and expand the PAK2 genotype and phenotype spectrum.

Methods

This study included a Chinese family with a proband who primarily presented with epilepsy and developmental delay. Whole‐exome sequencing and Sanger sequencing were performed to analyze potential variants. Structural modeling was performed to assess the impact of the variant on the protein structure. In vitro, a mutant plasmid was constructed and transfected into 293T cells to conduct phosphorylation assays, and phosphorylation levels at Ser141 of PAK2 were assessed. The PAK kinase inhibitor FRAX597 was used to confirm the specificity of the western blot results.

Results

A de novo variant of PAK2 gene, NM_002577.4: c.1049G>A (p.Arg350Lys) was found in the patient but not in his parents or sister. This variant was found to be located in the kinase domain and may alter the hydrogen‐bond network, potentially affecting kinase activity. In vitro functional experiments demonstrated that the variant may lead to reduced protein levels. Moreover, Western blot analysis showed a significant decrease in the phosphorylation level at Ser141 compared to the wild‐type plasmid, indicating that the variant may lead to decreased PAK2 phosphorylation levels.

Conclusion

The clinical manifestations in this patient may be associated with a novel PAK2 variant, and the atypical presentation of KNO suggests that PAK2‐related KNO may have a broader phenotypic spectrum.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

p21-Activated KinasesHumansMalePhosphorylationPedigreeFemaleMutation, MissenseChildPhenotypeChild, PreschoolHEK293 CellsEast Asian People

Stichwörter der Autor:innen

KNO2Knobloch syndromePAK2p21‐activated kinasephosphorylation

Substanzen

p21-Activated KinasesPAK2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Anhui Provincial Children's Hospital/Children's Hospital of Fudan University (Affiliated Anhui Branch), Hefei, China.

ORCID-Profile: Bin Yang

Förderung

  • Anhui Medical University Research Fund

Zitieren

APA

Shen, L., Ye, X., Wang, X., Song, C., & Yang, B. (2025). Chinese Family With Knobloch Syndrome Associated With a Novel PAK2 Variant Leading to Reduced Phosphorylation Levels. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.70099

Vancouver

Shen L, Ye X, Wang X, Song C, Yang B. Chinese Family With Knobloch Syndrome Associated With a Novel PAK2 Variant Leading to Reduced Phosphorylation Levels. Molecular Genetics & Genomic Medicine. 2025. doi:10.1002/mgg3.70099

BibTeX
@article{Shen2025,
  author = {Shen, Liwei and Ye, Xiaofei and Wang, Xiaocui and Song, Conglei and Yang, Bin},
  title = {Chinese Family With Knobloch Syndrome Associated With a Novel PAK2 Variant Leading to Reduced Phosphorylation Levels},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2025},
  doi = {10.1002/mgg3.70099}
}
Kostenlos starten →